Olon works with Zymvol on biocatalysis

Italian-based CDMO Olon has formed a strategic collaboration with Zymvol that it said is “designed to accelerate the adoption of biocatalysis as a practical, scalable manufacturing solution for the pharmaceutical industry”. No terms were disclosed.

This brings together Zymvol’s advanced computational enzyme design techniques with Olon’s industrial-scale biomanufacturing, large-scale (5,000 m3) microbial fermentation, process development and capabilities. Zymvol’s platform will support Olon’s customer and proprietary projects, while Olon will make its infrastructure available for Zymvol’s self-funded and customer-partnered programmes.